167 related articles for article (PubMed ID: 30409101)
21. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
23. Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report.
Rojas-Espaillat L; Houck KL; Hernandez E; Berkowitz RS
J Reprod Med; 2007 May; 52(5):431-4. PubMed ID: 17583247
[TBL] [Abstract][Full Text] [Related]
24. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Rattanaburi A; Boonyapipat S; Supasinth Y
Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
[TBL] [Abstract][Full Text] [Related]
25. Primary Gestational Trophoblastic Disease of the Fallopian Tube: A Case Series Analysis and Literature Review.
Lu J; Yue X; Xu C; Lu X
J Reprod Med; 2017; 62(3-4):147-52. PubMed ID: 30230306
[TBL] [Abstract][Full Text] [Related]
26. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
27. Hysteroscopic Intact Removal of an Angular Pregnancy with a 5Fr Electrode.
Mollo A; Raffone A; Improda FP; Travaglino A; Saccone G; Giampaolino P; Zullo F; De Placido G
J Minim Invasive Gynecol; 2019 Jan; 26(1):32-33. PubMed ID: 29602002
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia.
Garavaglia E; Gentile C; Cavoretto P; Spagnolo D; Valsecchi L; Mangili G
Am J Obstet Gynecol; 2009 Apr; 200(4):417.e1-5. PubMed ID: 19200936
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
30. Persistent free-floating pelvic trophoblastic cysts following an interstitial ectopic pregnancy.
Crawford KD; Chen MJ; Hou MY; Creinin MD
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439571
[TBL] [Abstract][Full Text] [Related]
31. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
[TBL] [Abstract][Full Text] [Related]
32. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
[TBL] [Abstract][Full Text] [Related]
33. Gestational trophoblastic neoplasia in adolescents.
Rauh-Hain JA; Growdon WB; Braga A; Goldstein DP; Berkowitz RS
J Reprod Med; 2012; 57(5-6):237-42. PubMed ID: 22696819
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
Li B; Wan X; Liang Y; Lu B; Lu W
J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951
[TBL] [Abstract][Full Text] [Related]
37. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988
[TBL] [Abstract][Full Text] [Related]
38. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
39. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
Feng F; Xiang Y; Li L; Wan X; Yang X
Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
[TBL] [Abstract][Full Text] [Related]
40. [Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Cao Y; Xiang Y; Feng FZ; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):928-30. PubMed ID: 19134333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
